Clinical Trial Update: Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo [Phase 4]

View source ↗

Summary

Phase 4 study comparing ropinirole extended-release (Requip CR) to placebo for SSRI-induced sexual dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sexual Dysfunction

Drugs mentioned

• Requip CR (ropinirole (extended-release))

Snippet

Sponsor: St. Luke's-Roosevelt Hospital Center | Conditions: Sexual Dysfunction | Phase 4 | Status: COMPLETED